Recipharm and CTC Clinical Trial form new Phase I pact

Published: 18-Jun-2014
Research & Development Pharmaceutical

Aiming to shorten project time lines


Recipharm Pharmaceutical Development, based in Solna, Stockholm, has entered into a collaboration with Uppsala-based CTC Clinical Trial Consultants to offer a complete set of packages for Phase I studies including development and manufacture of clinical trial material. The partnership will cover planning, performing and evaluation of the clinical trial.

Maria Lundberg, General Manager, Recipharm Pharmaceutical Development, said the two companies would be able to offer customers faster and more cost-effective Phase I studies.

Bengt Dahlström, CEO of CTC Clinical Trial, added: 'This systematic integrated approach will help our clients to shorten project time-lines and at the same time obtain more information on the desirable properties of the drug formulation.'

  • Companies:
  • Recipharm
  • CTC Clinical Trial Consultants
See more

You may also like

Manufacturing

Recipharm expands oral solid development and pilot scaling capabilities at Zwickau site

Read more
The CDMO's facility now has a range of pilot-scale OSD manufacturing capabilities, such as blending, hard capsule filling and tableting

Trending Articles

  1. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  2. The colouration of tablets and capsules Paul Smith from Sensient Pharmaceutical Technologies discusses the use of colour in solid oral dosage forms
  3. Optimising the blending of flow aids in powder formulations Flow aids are used routinely in pharmaceutical manufacturing to enhance the process performance of powder blends and safeguard the critical quality attributes of finished products
  4. Thermo Fisher Scientific reveals MagMax Sequential DNA/RNA Kit to advance blood cancer research The kit combines DNA and RNA isolation chemistries into a single kit, simplifying sample extraction for a broad range of downstream molecular applications
  5. Precise and efficient VARIO diaphragm pumps from Vacuubrand Advanced vacuum control for reproducible processes

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Recipharm expands oral solid development and pilot scaling capabilities at Zwickau site

The CDMO's facility now has a range of pilot-scale OSD manufacturing capabilities, such as blending, hard capsule filling and tableting
Research & Development

A new frontier: exploring the future of ATMP development

Advanced therapy medicinal products (ATMPs) are at the cutting edge of medical innovation, offering treatment options for diseases with few or no effective alternatives(1–3)
Research & Development

ReciBioPharm and GeneVentiv Therapeutics partner to advance AAV-based gene therapy

The collaboration will endeavour to progress the first AAV-based gene therapy to treat patients with haemophilia
Drug Delivery

Partnership speeds the development of pressurised metered dose inhalers

Honeywell has partnered with CDMO Recipharm on a commercial partnership that will speed the development of pressurised metered dose inhalers
Manufacturing

Recipharm’s analytical lab brings testing capabilities to global markets

Fully cGMP/cGLP compliant, the 5,000 sqft lab will expand Recipharm’s existing analytical capabilities and provide support for biotech and pharma customers
Drug Delivery

Arranta Bio signs contract for continuous mRNA manufacturing tech

The contract with the CDMO is part of the FDA’s initiative to have a fully integrated, continuous manufacturing production line for mRNA vaccines
Media

Industry spotlight: packaging trends in turbulent times

As if Brexit, the scaled-up production of vaccines and spiralling demand for cold chain storage wasn’t enough, Dr Kevin Robinson spoke to Recipharm’s Lukas Spanier and Sharp Services’ Alexander Schäfer to get an insider’s view on the biggest pharmaceutical packaging trends of 2021
Subscribe now